Explore /
Poster
/ Feasibility of an explainable AI-based therapeutic recommendation-tool utilizing tumor gene expression profiles in advanced and refractory solid tumors.

Feasibility of an explainable AI-based therapeutic recommendation-tool utilizing tumor gene expression profiles in advanced and refractory solid tumors.

Authors

Ouissam Al Jarroudi

Department of translational medicine, Centre Léon Bérard, Lyon, France

Ouissam Al Jarroudi , Coralie Williams , Rita Santos , Armelle Dufresne , Valéry Attignon , Anthony Ferrari , Sandrine Boyault , Laurie Tonon , Séverine Tabone-Eglinger , Philippe Alexandre Cassier , Nadège Corradini , Armelle Vinceneux , Aurélie Swalduz , Alain Viari , Sylvie Chabaud , David Pérol , Mohammad Afshar , Jean-Yves Blay , Olivier Tredan , Pierre Saintigny

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Care Delivery and Regulatory Policy

Track

Care Delivery and Quality Care

Sub Track

Clinical Informatics/Advanced Algorithms/Machine Learning

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 1554)

DOI

10.1200/JCO.2022.40.16_suppl.1554

Abstract #

1554

Poster Bd #

147

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Annual Meeting

BrUOG 387: Phase Ib investigator-initiated trial of a heat shock protein 90 inhibitor (HSP90i) combined with a CDK4/6i in advanced breast cancer progressing on CDK4/6i and in solid tumors with retinoblastoma (Rb)-deficiency (IND163592).

First Author: Wafik S. El-Deiry

Poster

2023 ASCO Gastrointestinal Cancers Symposium

$Pyrotinib combined with SHR6390 in the treatment of refractory advanced HER2-positive gastric cancer or solid tumors: Safety and efficacy results from a phase Id trial.$